Ultromics
Applies artificial intelligence to echocardiograms for automated heart failure diagnosis.
What they do
Develops AI powered software designed to analyze echocardiograms, improving the accuracy of heart failure and coronary artery disease detection. The software is used by hospital systems and cardiologists to standardize ultrasound interpretation and reduce diagnostic errors.
The record
- Vertical
- Cardiovascular
- Sub-segment
- Echocardiography analysis AI
- Product type
- Software as a medical device
- Stage
- Series B
- Headquarters
- Oxford, United Kingdom
- Region
- Europe
- Founded
- 2017
- Total funding
- $50M raised
Notable investors: Blue Venture Fund, Optum Ventures, Oxford Science Enterprises, LDV Partners.